Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections. [electronic resource]
Producer: 20011011Description: 19-27 p. digitalISSN:- 0924-8579
- Adult
- Aged
- Anti-Infective Agents -- administration & dosage
- Bronchitis -- drug therapy
- Chronic Disease
- Community-Acquired Infections -- drug therapy
- Drug Administration Schedule
- Female
- Fluoroquinolones
- Gemifloxacin
- Gram-Negative Bacterial Infections -- drug therapy
- Haemophilus Infections -- drug therapy
- Humans
- Klebsiella Infections -- drug therapy
- Male
- Middle Aged
- Naphthyridines -- administration & dosage
- Pneumococcal Infections -- drug therapy
- Pneumonia, Bacterial -- drug therapy
- Staphylococcal Infections -- drug therapy
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.